Mangoceuticals (MGRX) Change in Cash (2023 - 2026)

Mangoceuticals (MGRX) has 4 years of Change in Cash data on file, last reported at -$1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 12932.4% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at $99038.0 (up 56.35% YoY), and the FY2025 full-year result was $1.4 million, up 311.87% from the prior year.
• Change in Cash slipped to -$1.3 million in Q1 2026, from $1.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $3.2 million in Q1 2023 to a low of -$1.7 million in Q3 2023.
• A 4-year average of -$38854.2 and a median of -$7077.0 in 2024 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash soared 14311.36% in 2025 and slumped 12932.4% in 2026, its largest moves.
• Tracing MGRX's Change in Cash over 4 years: stood at -$497741.0 in 2023, then soared by 98.58% to -$7077.0 in 2024, then soared by 14311.36% to $1.0 million in 2025, then tumbled by 230.39% to -$1.3 million in 2026.
• Business Quant data shows MGRX's Change in Cash at -$1.3 million in Q1 2026, $1.0 million in Q4 2025, and $380307.0 in Q3 2025.